Ifp Advisors, Inc Ocular Therapeutix, Inc Transaction History

Ifp Advisors, Inc

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$8.33 - $11.47 $0 - $0	0 New	0 $0
Q4 2022 Feb 07, 2023	SELL	$2.61 - $4.41 $1,305 - $2,205	-500 Reduced 33.33%	1,000 $7,000
Q2 2022 Sep 06, 2022	BUY	$3.01 - $5.22 $4,515 - $7,830	1,500 New	1,500 $10,000
Q2 2022 Aug 12, 2022	SELL	$3.01 - $5.22 $4,515 - $7,830	-1,500 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$4.83 - $7.35 $7,245 - $11,025	1,500 New	1,500 $7,000
Q3 2021 Oct 06, 2021	SELL	$9.7 - $14.34 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$13.43 - $19.16 $20,145 - $28,740	-1,500 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$7.91 - $22.95 $11,865 - $34,425	1,500 New	1,500 $31,000

180

136M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $627M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.